Search research articles
Contact Us
Filters
Showing results (91-100 of 222) with videos related to
Page
of 23
Sort By:
Cancer Research
|
March 22, 2003
Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study
John Farley, Leia M Smith, Kathleen M Darcy, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
March 5, 2021
A prognostic system for epithelial ovarian carcinomas using machine learning
Philip M Grimley, Zhenqiu Liu, Kathleen M Darcy, et al.
Journal of Technology in Behavioral Science
|
October 31, 2018
The Utility and Acceptability of a Self-Help Smartphone Application for Eating Disorder Behaviors
Jane Paik Kim, Shiri Sadeh-Sharvit, Alison M Darcy, et al.
Eating Disorders
|
February 17, 2018
Subgrouping the users of a specialized app for eating disorders
Shiri Sadeh-Sharvit, Jane Paik Kim, Alison M Darcy, et al.
Oncogene
|
September 22, 2010
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer
X He, A D Arslan, M D Pool, et al.
Eating Disorders
|
April 11, 2017
A qualitative analysis of male eating disorder symptoms
Katherine D Arnow, Talya Feldman, Elizabeth Fichtel, et al.
Gynecologic Oncology
|
March 23, 2006
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study
, Angeles Alvarez Secord, Paula S Lee, et al.
Gynecologic Oncology
|
February 22, 2005
Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study
Agustin A Garcia, John A Blessing, Heinz-Josef Lenz, et al.
Gynecologic Oncology
|
February 20, 2007
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study
D Scott McMeekin, Michael W Sill, Doris Benbrook, et al.
Gynecologic Oncology Reports
|
February 16, 2022
Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study
Cheng-I Liao, Michelle Ann Caesar, Danny Lee, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 222) with videos related to
Sort By:
Page
of 23
Cancer Research
|
March 22, 2003
Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study
John Farley, Leia M Smith, Kathleen M Darcy, et al.
Acta Obstetricia Et Gynecologica Scandinavica
|
March 5, 2021
A prognostic system for epithelial ovarian carcinomas using machine learning
Philip M Grimley, Zhenqiu Liu, Kathleen M Darcy, et al.
Journal of Technology in Behavioral Science
|
October 31, 2018
The Utility and Acceptability of a Self-Help Smartphone Application for Eating Disorder Behaviors
Jane Paik Kim, Shiri Sadeh-Sharvit, Alison M Darcy, et al.
Eating Disorders
|
February 17, 2018
Subgrouping the users of a specialized app for eating disorders
Shiri Sadeh-Sharvit, Jane Paik Kim, Alison M Darcy, et al.
Oncogene
|
September 22, 2010
Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer
X He, A D Arslan, M D Pool, et al.
Eating Disorders
|
April 11, 2017
A qualitative analysis of male eating disorder symptoms
Katherine D Arnow, Talya Feldman, Elizabeth Fichtel, et al.
Gynecologic Oncology
|
March 23, 2006
Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study
, Angeles Alvarez Secord, Paula S Lee, et al.
Gynecologic Oncology
|
February 22, 2005
Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study
Agustin A Garcia, John A Blessing, Heinz-Josef Lenz, et al.
Gynecologic Oncology
|
February 20, 2007
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study
D Scott McMeekin, Michael W Sill, Doris Benbrook, et al.
Gynecologic Oncology Reports
|
February 16, 2022
Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study
Cheng-I Liao, Michelle Ann Caesar, Danny Lee, et al.
Page
of 23